Black Nightshade with reduced pathogenesis-related protein 1S synthesis | BCH-LMO-SCBD-108714 | Living Modified Organism | Biosafety Clearing-House

Loading...
Living Modified Organism (LMO)
  |  
BCH-LMO-SCBD-108714-3   |   PDF   |   Print   |  
Decisions on the LMO Risk Assessments  
last updated: 12 Mar 2024
Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
Black Nightshade with reduced pathogenesis-related protein 1S synthesis
EN
S03/144-2
No
In the transgenic plants of the line S03/144-2 the synthesis of the plant's pathogenesis-related (PR) protein 1S is to be reduced by post transcriptional gene silencing.

The pr-1S gene derived from Solanum nigrum codes for a PR protein. PR proteins are encoded by the host plant in response to pathogen attacks or comparable stress factors.

For this purpose, a construct was developed in which two complementary internal fragments of the pr-1S gene derived from Solanum nigrum were arranged in sense and antisense orientation, separated by a spacer. As a result of the genetic modification, the resistance of the transgenic plant to phytopathogenic microorganisms is reduced by targeted reduction of the formation of the PR-1S protein.
EN
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
EN
  • Black Nightshade with reduced pathogenesis-related protein 1S synthesis.
    | Resistance to antibiotics (Hygromycin), Resistance to diseases and pests
  • Black nightshade modified for reduced production of endogenous prosystemin
    | Resistance to antibiotics (Hygromycin), Resistance to diseases and pests
  • Black nightshade modified for reduced production of endogenous proteinase inhibitors
    | Resistance to antibiotics (Hygromycin), Resistance to diseases and pests (Insects)
Characteristics of the modification process
pSOL3PRIS
EN
  • Agrobacterium-mediated DNA transfer
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
  • BCH-GENE-SCBD-100269-8 Nopaline Synthase Gene Terminator | Agrobacterium tumefaciens (Agrobacterium)
    Terminator
  • BCH-GENE-SCBD-14991-8 Hygromycin B phosphotransferase gene | Escherichia coli (ECOLX)
    Protein coding sequence | Resistance to antibiotics (Hygromycin),Selectable marker genes and reporter genes
  • BCH-GENE-SCBD-100270-6 Nopaline Synthase Gene Promoter | Agrobacterium tumefaciens (Agrobacterium)
    Promoter
  • BCH-GENE-SCBD-100287-7 CaMV 35S promoter | Cauliflower mosaic virus (CaMV)
    Promoter
  • BCH-GENE-SCBD-103123-6 Pyruvate orthophosphate dikinase, Intron 3 | Flaveria trinervia (Clustered Yellowtops, speedyweed, flaveria, yellow twinstem)
    Intron
  • BCH-GENE-SCBD-108712-1 Pathogenesis-related protein 1S gene | Solanum nigrum (Black nightshade, SOLNI)
    Protein coding sequence | Resistance to diseases and pests
  • BCH-GENE-SCBD-100290-6 CaMV 35S terminator | Cauliflower mosaic virus (CaMV)
    Terminator
The plasmid pSOL3PRIS used for transformation includes a construct, in which two complementary 295 bp long internal fragments of the pr-1S gene derived from Solanum nigrum were arranged in sense and antisense orientation, separated by a spacer. The 785 bp long third intron of the pyruvate orthophosphate dikinase gene (pdk i3) of Flaveria trinervia, of which splicing activity is suspected, was used as a spacer. Expression is controlled by the promoter and the terminator of the 35S gene of the cauliflower mosaic virus (CaMV).

The hygromycin phosphotransferase gene (hptII) of Escherichia coli expressed under the control of the promoter and terminator of the nopaline synthase gene of Agrobacterium tumefaciens was used as a selection marker. The introduced nucleic acid is integrated in the genome of the recipient organism.
EN
LMO characteristics
EN
  • Research
Detection method(s)
EN
Additional Information
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Living modified organism(s) 1
Living Modified Organism Related LMO(s) 3
Risk Assessment generated by a regulatory process Living modified organism(s) 1